AZTR - Azitra, Inc.
0.1804
0.004 2.439%
Share volume: 327,377
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.18
0.00
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-12-2024 | 02-24-2025 | 05-13-2025 | 11-12-2025 | 02-27-2026 | |
| Total revenue | 0.000 | 7.500 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 7.500 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| inf% | -100.00% | nan% | nan% | nan% | ||||
| Operating expenses | 2.961 M | 2.668 M | 2.929 M | 2.434 M | 3.100 M | 2.768 M | 2.227 M | |
| Selling general and admin | 1.489 M | 1.549 M | 1.913 M | 1.318 M | 1.850 M | 1.588 M | 1.223 M | |
| Research and development | 1.473 M | 1.119 M | 1.016 M | 1.116 M | 1.250 M | 1.180 M | 1.004 M | |
| Total expenses | 2.961 M | 2.668 M | 2.929 M | 2.434 M | 3.100 M | 2.768 M | 2.227 M | |
| -9.92% | 9.80% | -16.90% | 27.36% | -10.70% | -19.57% | |||
| Operating income | -2.961 M | -2.660 M | -2.929 M | -2.434 M | -3.100 M | -2.768 M | -2.227 M | |
| Ebit | -2.940 M | -2.646 M | -1.053 M | -2.430 M | -3.104 M | -2.769 M | -2.232 M | |
| Pretax income | -2.933 M | -2.632 M | -1.009 M | -2.384 M | -3.068 M | -2.765 M | -2.225 M | |
| -10.26% | -61.65% | 136.17% | 28.70% | -9.90% | -19.51% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 9.031 K | 0.000 | 0.000 | 8.319 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.933 M | -2.632 M | -1.009 M | -2.393 M | -3.068 M | -2.765 M | -2.234 M | |
| 10.26% | 61.65% | -137.06% | -28.21% | 9.90% | 19.21% |